CHICAGO, May 29 – Micromass and Bio-Rad Laboratories have entered a deal to sell their jointly developed proteomics platform to the European Molecular Biology Laboratory in Heidelberg, Germany, a Micromass spokesman said Tuesday.

The ProteomeWorks System, a platform of integrated technologies, includes Bio-Rad’s 2-D gel electrophoresis and liquid chromatography instruments and Micromass’ Maldi-TOF mass spectrometry instrument, as well as sample preparation kits and consumables, bioinformatics software, and image analysis tools.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.